DUSA PHARMACEUTICALS INC (DUSA.O): * Third quarter GAAP per
share loss $0.10 * Third quarter revenue $5.78 million * Third
quarter non-GAAP per share loss $0.07 * Reuters Estimates third
quarter earnings per share view $-0.16, revenue view $5.91
million
WASHINGTON (Reuters) - The White House on Sunday urged support for a compromise that would allow healthcare reform legislation to pass the U.S. Senate and pushed back against other Democrats who said the compromise gives away too much. | Video
On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America? Full Article
The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
